Skip to main content

Table 2 Adverse events following vaccination in patients with AD and CG

From: Safety of inactivated SARS-CoV-2 vaccines in patients with allergic diseases

 

After first dose

After second dose

 

AD (n = 381)

CG (n = 1545)

P value

AD (n = 381)

CG (n = 1545)

P value

No symptoms

181 (47,5)

968 (62.7)

 < 0.001

232 (60.9)

1166 (75.5)

 < 0.001

Local reaction

124 (32.5)

309 (20.0)

 < 0.001

106 (27.8)

253 (16.4)

 < 0.001

Pain

118 (31.0)

292 (18.9)

 < 0.001

99 (26.0)

232 (15.0)

 < 0.001

Redness

3 (0.8)

8 (0.5)

0.806

4 (1.0)

11 (0.7)

0.729

Swelling

10 (2.6)

26 (1.7)

0.224

11 (2.9)

27 (1.7)

0.152

Pruritus

0

4 (0.3)

1.000

0

3 (0.2)

1.000

Malaise

0

2 (0.1)

1.000

0

1 (0.1)

1.000

Systemic reactions

115 (30.2)

354 (22.9)

0.003

65 (17.1)

172 (11.1)

0.002

Fever

7 (1.8)

28 (1.8)

0.974

5 (1.3)

14 (0.9)

0.668

Chills

8 (2.1)

8 (0.5)

0.006

0 (0.0)

5 (0.3)

0.590

Fatigue

62 (16.3)

151 (9.8)

 < 0.001

30 (7.9)

77 (5.0)

0.027

Headache

12 (3.1)

17 (1.1)

0.003

6 (1.6)

5 (0.3)

0.012

Vertigo

22 (5.8)

50 (3.2)

0.019

10 (2.6)

25 (1.6)

0.188

Somnolence

4 (1.0)

25 (1.6)

0.561

4 (1.0)

10 (0.6)

0.623

Vomiting

6 (1.6)

14 (0.9)

0.249

1 (0.3)

4 (0.3)

1.000

Diarrhea

12 (3.1)

24 (1.6)

0.039

3 (0.8)

14 (0.9)

0.933

Abdominal pain

1 (0.3)

6 (0.4)

0.913

0

3 (0.2)

1.000

Stuffy nose

6 (1.6)

16 (1.0)

0.375

3 (0.8)

10 (0.6)

0.960

Sore throat

11 (2.9)

27 (1.7)

0.152

7 (1.8)

16 (1.0)

0.197

Cough

4 (1.0)

14 (0.9)

0.971

5 (1.3)

9 (0.6)

0.244

Chest pain

0

1 (0.1)

1.000

0

0

1.000

Cardiopalmus

1 (0.3)

3 (0.2)

0.586

1 (0.3)

3 (0.2)

0.586

New or worsened muscle pain

7 (1.8)

15 (1.0)

0.154

7 (1.8)

13 (0.8)

0.151

New or worsened joint pain

1 (0.3)

3 (0.2)

0.586

1 (0.3)

4 (0.3)

1.000

Skin rash

12 (3.1)

19 (1.2)

0.008

6 (1.6)

7 (0.5)

0.041